18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations

The objective of this article is to provide an illustrative tutorial highlighting the utility of 18F-FDG PET/CT imaging to detect the spectrum of manifestations in patients with Langerhans cell histiocytosis. FDG PET/CT is a powerful tool for making an early diagnosis; it allows higher diagnostic co...

Full description

Saved in:
Bibliographic Details
Published in:Japanese journal of radiology 2016-04, Vol.34 (4), p.267-276
Main Authors: Agarwal, Krishan Kant, Seth, Rachna, Behra, Abhishek, Jana, Manisha, Kumar, Rakesh
Format: Article
Language:English
Subjects:
Fluorodeoxyglucose F18
Histiocytosis, Langerhans-Cell - diagnostic imaging
Humans
Imaging
Medicine
Medicine & Public Health
Nuclear Medicine
Pictorial Essay
Positron Emission Tomography Computed Tomography
Radiology
Radiopharmaceuticals
Radiotherapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The objective of this article is to provide an illustrative tutorial highlighting the utility of 18F-FDG PET/CT imaging to detect the spectrum of manifestations in patients with Langerhans cell histiocytosis. FDG PET/CT is a powerful tool for making an early diagnosis; it allows higher diagnostic confidence with regard to lesions, measuring the extent of disease (staging) and assessing disease activity, and is consequently useful for evaluating the response to therapy in patients with Langerhans cell histiocytosis.
ISSN:1867-1071
1867-108X
DOI:10.1007/s11604-016-0517-7